Company / Operating Cash Flow
Opus Genetics, Inc. Operating Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$25.6M
FY2025
5-year range
-$25.6M / $14.3M
FY2021-FY2025
Trend
-2200.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow changed -2200% YoY in FY2025, a notable deviation from the 6-year average annual change of -392%.
Based on SEC 10-K filings.
-$26M in FY2025.
Declined from $14M to -$26M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 2200.0% year-over-year.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$25.6M | -2200.0% |
| FY2024 | -$1.1M | -107.8% |
| FY2023 | $14.3M | +173.9% |
| FY2022 | -$19.4M | -185.0% |
| FY2021 | -$6.8M | -2.7% |
| FY2013 | -$6.6M | -28.6% |
| FY2011 | -$5.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026